Editorials
Comparing risk prediction models
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3186 (Published 24 May 2012) Cite this as: BMJ 2012;344:e3186
Related articles
- Research Published: 24 May 2012; BMJ 344 doi:10.1136/bmj.e3318
- Research Methods & Reporting Published: 28 May 2009; BMJ 338 doi:10.1136/bmj.b605
- Research Methods & Reporting Published: 04 June 2009; BMJ 338 doi:10.1136/bmj.b606
- Research Published: 18 September 2012; BMJ 345 doi:10.1136/bmj.e5900
- Research Methods & Reporting Published: 07 January 2015; BMJ 350 doi:10.1136/bmj.g7594
- Research Published: 08 September 2015; BMJ 351 doi:10.1136/bmj.h4438
- Research Published: 16 May 2016; BMJ 353 doi:10.1136/bmj.i2416
- Research Methods & Reporting Published: 22 June 2016; BMJ 353 doi:10.1136/bmj.i3140
- Research Published: 30 August 2016; BMJ 354 doi:10.1136/bmj.i4338
- Research Methods & Reporting Published: 20 March 2020; BMJ 368 doi:10.1136/bmj.l6927
- Research Published: 28 September 2021; BMJ 374 doi:10.1136/bmj.n2134
- Research Methods & Reporting Published: 07 February 2023; BMJ 380 doi:10.1136/bmj-2022-071058
See more
- Patients with asthma or heart disease should avoid incense sticks and other airborne pollutants, says CMOBMJ June 03, 2025, 389 r1146; DOI: https://doi.org/10.1136/bmj.r1146
- Why are UK cardiovascular deaths in under 65s rising again?BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015
- Prescribing parkrun: medicalising a walk in the parkBMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670
- GPs can prescribe tirzepatide to priority patient groups from JuneBMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665
- Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reportsBMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287
Cited by...
- Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration
- Developing, validating, updating and judging the impact of prognostic models for respiratory diseases
- Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study
- Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness
- Prediction modelling of inpatient neonatal mortality in high-mortality settings
- Prognostic models for predicting in-hospital paediatric mortality in resource-limited countries: a systematic review
- Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys
- External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study
- External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges
- Prediction models for cardiovascular disease risk in the general population: systematic review
- Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care
- Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
- Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study